Copyright
©The Author(s) 2015.
World J Hepatol. Jun 18, 2015; 7(11): 1586-1594
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1586
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1586
Table 2 Summary of the characteristics of participants (n = 442)
Characteristics | |
Age (yr) | 49.1 ± 14.2 |
Gender | |
Female | 290 (65.6) |
Male | 152 (34.4) |
BMI (kg/m2) | 31.3 ± 6.1 |
Hepatic steatosis | 230 (52.0) |
Elevated ALT1 | 128 (29.0) |
Elevated AST2 | 129 (29.2) |
Albumin (g/dL) | 4.0 (3.8-4.2) |
Platelet (109/μL) | 243.5 (207.0-282.0) |
DM3 | 97 (21.9) |
Hypertension | 167 (37.8) |
Hyperglycemia | 134 (30.3) |
Hypertriglyceridemia | 175 (39.6) |
Low HDL-C | 267 (60.4) |
Central obesity | 324 (73.3) |
Metabolic syndrome | 219 (49.5) |
NAFLD fibrosis score | |
< -1.455 | 244 (55.2) |
-1.455-0.676 | 169 (38.2) |
> 0.676 | 29 (6.6) |
FIB4 index | |
≤ 1.31 | 323 (73.1) |
1.31-2.66 | 106 (24.0) |
≥ 2.67 | 13 (2.9) |
BARD | |
0-1 | 163 (36.9) |
2-4 | 279 (63.1) |
APRI | |
≤ 0.5 | 365 (82.6) |
0.51-1.5 | 73 (16.5) |
> 1.5 | 4 (0.9) |
- Citation: Pan JJ, Fisher-Hoch SP, Chen C, Feldstein AE, McCormick JB, Rahbar MH, Beretta L, Fallon MB. Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. World J Hepatol 2015; 7(11): 1586-1594
- URL: https://www.wjgnet.com/1948-5182/full/v7/i11/1586.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i11.1586